Athanor Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Athanor Capital’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8,784	Closed	-$380K	–	1094
2020 Q4	$380K	Buy	+8,784	New	+$433K	0.01%	530
2020 Q3	–	Sell	-9,734	Closed	-$615K	–	707
2020 Q2	$615K	Buy	+9,734	New	+$668K	0.03%	268
2020 Q1	–	Sell	-18,700	Closed	-$1.49M	–	396
2019 Q4	$1.49M	Buy	18,700 +2,100	+13%	+$124K	0.07%	130
2019 Q3	$805K	Buy	+16,600	New	+$865K	0.05%	131

Other funds holding GBT

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Athanor Capital's GBT Position: Q1 2021 in Review

Athanor Capital sold out of Global Blood Therapeutics, Inc. (GBT) in Q1 2021, closing a stake of 8,784 shares — an estimated $380K sold.

Athanor Capital first reported a position in GBT in Q3 2019 and held it in 4 quarters. The position peaked at $1.49M in Q4 2019. 214 funds tracked by Wall St. Rank hold GBT as of Q1 2021.

Athanor Capital reported no remaining Global Blood Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
Athanor Capital sold 8,784 Global Blood Therapeutics, Inc. shares in Q1 2021, an estimated $380K.
Athanor Capital first reported a position in Global Blood Therapeutics, Inc. in Q3 2019 and held it in 4 quarters.
Athanor Capital's Global Blood Therapeutics, Inc. position peaked at $1.49M in Q4 2019.
214 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2021.

Based on Athanor Capital's 13F filing for Q1 2021, filed 14 May 2021.